Home > Insider Trading > Ani Pharmaceuticals Inc > Profile

Ani Pharmaceuticals Inc (ANIP)

Market is closed

Sector: Pharmaceutical Preparations

Insider Roster

Andrew Thomas Rowland, Svp, Head - Established Brands, 2026-02-17
Christopher Mutz, Head Of Rare Disease, 2026-02-17
Nikhil Lalwani, President & Ceo, 2026-02-17

Andrew Thomas Rowland, Svp, Head - Established Brands, 2026-02-17
Christopher Mutz, Head Of Rare Disease, 2026-02-17
Nikhil Lalwani, President & Ceo, 2026-02-17
Ori Gutwerg, Svp, Generics, 2026-02-17
Chad Gassert, Svp - Corp. Dev. & Strategy, 2026-02-17
Krista Davis, Svp, Chief Hr Officer, 2026-02-17
Meredith Cook, Sr. Vp, General Counsel & Sec., 2026-02-17
P. Stephen Carey, Svp & Cfo, 2026-02-17
Muthusamy Shanmugam, Head Of R&D, Coo-Novitium Ops, 2026-02-13
P Renee Tannenbaum, Director, 2025-12-09
D Patrick Walsh, Director, 2025-11-17
R Antonio Pera, Director, 2025-09-04
J Matthew Leonard, Director, 2025-08-26
Jeanne Thoma, Director, 2025-08-20
Thomas Haughey, Director, 2025-08-14
G. James Marken, Svp Ops & Prod Dev, 2024-06-11
Meridian Venture Partners Ii Lp, Large Shareholder, 2023-08-17
Meridian Venture Partners Ii Gp, L.p., Large Shareholder, 2023-08-17
Meridian Venture Partners Ii, Co., Large Shareholder, 2023-08-17
Jr E. Robert Brown, Large Shareholder, 2023-08-17
David Nash, Director, 2023-05-24
W Robert Schrepfer, Svp - New Bus Dev & Spec Sales, 2021-03-30
Arthur Przybyl, President and Ceo, 2020-04-08
A. Thomas Penn, Director, 2019-04-01
Tracy Marshbanks, Director, 2018-05-16
Fred Holubow, Director, 2018-03-22
Daniel Raynor, Director, 2018-03-19
C. Charlotte Arnold, Vice President and Cfo, 2016-04-11
A Peter Lankau, Director, 2016-04-11
J Ross Mangano, Director, 2014-09-16
J. Robert Jamnick, Vp, Quality & Product Develop., 2014-05-27
W Louis Sullivan, Director, 2012-03-30
Jr T John Potts, Director, 2012-03-30
Iii C Edward Rosenow, Director, 2012-03-30
A Stephen Sherwin, Director, 2012-03-30
C Michael Snabes, Sr. Vp Of Medical Affairs, 2012-01-27
B Philip Donenberg, Sr Vp Of Finance, Cfo, Secy, 2012-01-27
M Stephen Simes, Vice Chairman, President & Ceo, 2012-01-27
Peter Kjaer, Director, 2010-04-02

Show All Insiders (39)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on February 18, 2026, 2:56pm based on SEC 13F filings Last update: February 18, 2026, 2:56pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Millennium Management Israel Englander	539,665	$42,601,155	+728%	0.02%
2.	Soleus Capital Guy Levy	486,243	$38,384,022	+43%	1.42%
3.	Tang Capital Management Kevin C. Tang	481,437	$38,004,637	+52%	1.88%
4.	Deep Track Capital David Kroin	477,684	$37,708,375	+7%	0.67%
5.	Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell	473,207	$37,354,961	+32%	0.02%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Lalwani	$27.69	7,224	$199,997.16	169,650	2022-03-21	Filing
Walsh	$27.76	5,000	$138,794.00	53,388	2022-03-21	Filing
Gassert	$27.87	5,000	$139,342.50	393,226	2022-03-21	Filing
Gassert	$27.15	5,000	$135,744.00	388,226	2022-03-18	Filing
Shanmugam	$27.65	5,000	$138,251.50	5,000	2022-03-17	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Mutz Officer	$76.55	7,032	$538,299.60	92,566	2026-02-12	Filing
Cook Officer	$76.80	500	$38,400.00	69,329	2026-02-13	Filing
Cook Officer	$84.33	500	$42,165.00	74,374	2026-01-13	Filing
Davis Officer	$82.40	1,622	$133,652.80	58,564	2025-12-18	Filing
Cook Officer	$82.32	400	$32,928.00	74,874	2025-12-12	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management CorpBOND	300,000,000	$379,227,000	1.21%
2.	Blackrock, Inc.	2,661,712	$210,115,544	0%
3.	Vanguard Group Inc	1,305,068	$103,022,068	0%
4.	State Street Corp	727,204	$57,405,484	0%
5.	Camden Asset Management L PBOND	43,017,000	$54,072,369	1.37%

News See All

Click here to See All News